Literature DB >> 6294325

The B95-8 isolate of Epstein-Barr virus arose from an isolate with a standard genome.

J Skare, C Edson, J Farley, J L Strominger.   

Abstract

Blot hybridization studies revealed that the deletion which characterizes the DNA from the B95-8 strain of Epstein-Barr virus was not present in the virus from which the B95-8 strain was derived (883L). The deletion event must have occurred during establishment of the B95-8 cell line or very soon afterward, since the deletion was present in Epstein-Barr virus DNA from a cell line established with B95-8 virus soon after it became available. The presence of the deletion correlates with decreased expression of the gp220 viral envelope glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294325      PMCID: PMC256372     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  The structure of the termini of the DNA of Epstein-Barr virus.

Authors:  C R Kintner; B Sugden
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

2.  DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA.

Authors:  D Given; D Yee; K Griem; E Kieff
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

3.  Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a nontransforming virus by partial denaturation mapping of their DNAs.

Authors:  H Delius; G W Bornkamm
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

4.  DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus.

Authors:  D Given; E Kieff
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

5.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

6.  Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.

Authors:  C M Edson; D A Thorley-Lawson
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

7.  Cloning and mapping of BamHi endonuclease fragments of DNA from the transforming B95-8 strain of Epstein-Barr virus.

Authors:  J Skare; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

8.  Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs.

Authors:  G W Bornkamm; H Delius; U Zimber; J Hudewentz; M A Epstein
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

9.  DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative.

Authors:  N Raab-Traub; T Dambaugh; E Kieff
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

10.  Genome of a mononucleosis Epstein-Barr virus contains DNA fragments previously regarded to be unique to Burkitt's lymphoma isolates.

Authors:  D K Fischer; G Miller; L Gradoville; L Heston; M W Westrate; W Maris; J Wright; J Brandsma; W C Summers
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

  10 in total
  17 in total

1.  Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.

Authors:  Mu-Sheng Zeng; Da-Jiang Li; Qing-Lun Liu; Li-Bing Song; Man-Zhi Li; Ru-Hua Zhang; Xing-Juan Yu; Hui-Min Wang; Ingemar Ernberg; Yi-Xin Zeng
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H.

Authors:  J Skare; J Farley; J L Strominger; K O Fresen; M S Cho; H zur Hausen
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

3.  Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus.

Authors:  C M Edson; D A Thorley-Lawson
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

4.  Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor.

Authors:  Teru Kanda; Mamiko Miyata; Makoto Kano; Satoru Kondo; Tomokazu Yoshizaki; Hisashi Iizasa
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

5.  Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection.

Authors:  Eric R Weiss; Susanna L Lamers; Jennifer L Henderson; Alexandre Melnikov; Mohan Somasundaran; Manuel Garber; Liisa Selin; Chad Nusbaum; Katherine Luzuriaga
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

6.  Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos.

Authors:  Maria Vaysberg; Olivia Hatton; Stacie L Lambert; Andrew L Snow; Bonnie Wong; Sheri M Krams; Olivia M Martinez
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

7.  Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.

Authors:  K A Taylor; S Wetzel; D S Lyles; B A Pollok
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).

Authors:  R E Callard; Y L Lau; J G Shields; S H Smith; J Cairns; L Flores-Romo; J Gordon
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

9.  The full-length DNA sequence of Epstein Barr virus from a human gastric carcinoma cell line, SNU-719.

Authors:  Kyung-A Song; San-Duk Yang; Jinha Hwang; Jong-Il Kim; Myung-Soo Kang
Journal:  Virus Genes       Date:  2015-10-12       Impact factor: 2.332

10.  The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation.

Authors:  Anders Friberg; Sybille Thumann; Janosch Hennig; Peijian Zou; Elfriede Nössner; Paul D Ling; Michael Sattler; Bettina Kempkes
Journal:  PLoS Pathog       Date:  2015-05-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.